X-72130403-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001024455.4(RTL5):c.1138G>A(p.Glu380Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000153 in 1,173,012 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 44 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001024455.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000773 AC: 85AN: 109978Hom.: 0 Cov.: 22 AF XY: 0.000621 AC XY: 20AN XY: 32216
GnomAD3 exomes AF: 0.000115 AC: 17AN: 147256Hom.: 0 AF XY: 0.0000884 AC XY: 4AN XY: 45270
GnomAD4 exome AF: 0.0000903 AC: 96AN: 1062985Hom.: 0 Cov.: 32 AF XY: 0.0000740 AC XY: 25AN XY: 338025
GnomAD4 genome AF: 0.000763 AC: 84AN: 110027Hom.: 0 Cov.: 22 AF XY: 0.000589 AC XY: 19AN XY: 32275
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.1138G>A (p.E380K) alteration is located in exon 1 (coding exon 1) of the RGAG4 gene. This alteration results from a G to A substitution at nucleotide position 1138, causing the glutamic acid (E) at amino acid position 380 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at